Search details
1.
Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
Circulation
; 149(24): 1875-1884, 2024 Jun 11.
Article
in English
| MEDLINE | ID: mdl-38587557
2.
Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 103(4): 523-531, 2024 03.
Article
in English
| MEDLINE | ID: mdl-38440914
3.
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Eur Heart J
; 44(15): 1313-1330, 2023 04 17.
Article
in English
| MEDLINE | ID: mdl-36790101
4.
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.
Circulation
; 145(11): 847-863, 2022 03 15.
Article
in English
| MEDLINE | ID: mdl-35286164
5.
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Lancet
; 400(10361): 1405-1416, 2022 10 22.
Article
in English
| MEDLINE | ID: mdl-36130612
6.
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
Lancet
; 399(10333): 1401-1410, 2022 04 09.
Article
in English
| MEDLINE | ID: mdl-35390320
7.
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
N Engl J Med
; 382(13): 1208-1218, 2020 03 26.
Article
in English
| MEDLINE | ID: mdl-32050061
8.
Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
Catheter Cardiovasc Interv
; 102(3): 464-471, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37493431
9.
Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
Catheter Cardiovasc Interv
; 102(5): 814-822, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37676058
10.
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
Circulation
; 143(5): 479-500, 2021 02 02.
Article
in English
| MEDLINE | ID: mdl-33523728
11.
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
N Engl J Med
; 381(19): 1820-1830, 2019 11 07.
Article
in English
| MEDLINE | ID: mdl-31562798
12.
Randomized evaluation of vessel preparation with orbital atherectomy prior to drug-eluting stent implantation in severely calcified coronary artery lesions: Design and rationale of the ECLIPSE trial.
Am Heart J
; 249: 1-11, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35288105
13.
Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study.
Catheter Cardiovasc Interv
; 99(2): 263-270, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34582080
14.
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
Catheter Cardiovasc Interv
; 99(3): 583-592, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34478233
15.
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
Eur Heart J
; 42(45): 4638-4651, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34002203
16.
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.
Lancet
; 395(10234): 1444-1451, 2020 05 02.
Article
in English
| MEDLINE | ID: mdl-32234534
17.
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications.
Am Heart J
; 239: 90-99, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34052211
18.
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials.
Am Heart J
; 235: 140-148, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33609498
19.
Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries.
Am Heart J
; 236: 37-48, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33636137
20.
Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent.
Catheter Cardiovasc Interv
; 98(5): 848-856, 2021 11 01.
Article
in English
| MEDLINE | ID: mdl-32890442